Jubilant Therapeutics India Limited
Develops cancer treatment through small molecule discovery and development.
2019 | Ghaziabad, Uttar Pradesh (India) | Active
Jubilant Therapeutics India Profile
Key Indicators
- Authorised Capital ₹ 86.65 Cr
- Paid Up Capital ₹ 86.65 Cr
- Company Age 6 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 221.60%
- Profit Growth 558.81%
- Ebitda 125.29%
- Net Worth 11.29%
- Total Assets 12.90%
About Jubilant Therapeutics India
Jubilant Therapeutics India Limited (JTIL) is a Public Limited Indian Non-Government Company incorporated in India on 20 March 2019 (Six years 8 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 86.65 Cr and a paid-up capital of Rs 86.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Jubilant Therapeutics India Limited India are Arun Sharma as CFO and Anil Sharma as Company Secretary. Sanjay Gupta, Shyam Pattabiraman, Arvind Chokhany, and One other member serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74994UP2019PLC114901
- Company No.
114901
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2019
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Healthcare
Who are the key members and board of directors at Jubilant Therapeutics India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Sharma  | CFO | 18-Sep-2019 | Current |
| Anil Sharma | Company Secretary | 18-Sep-2019 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Gupta | Director | 16-Jul-2021 | Current |
| Shyam Pattabiraman | Director | 08-Sep-2020 | Current |
| Arvind Chokhany | Director | 03-Jun-2021 | Current |
| Sridharan Rajagopal | Whole-Time Director | 15-May-2019 | Current |
Financial Performance of Jubilant Therapeutics India.
Jubilant Therapeutics India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 221.6% increase. The company also saw a substantial improvement in profitability, with a 558.81% increase in profit. The company's net worth Soared by an impressive increase of 11.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jubilant Therapeutics India?
In 2023, Jubilant Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jubilant Bhartia FoundationArvind Chokhany is a mutual person
Jubilant Biosys LimitedArvind Chokhany is a mutual person
Jubilant Generics LimitedArvind Chokhany is a mutual person
Jubilant Business Services LimitedArvind Chokhany is a mutual person
Jubilant Pharmova LimitedArvind Chokhany is a mutual person
- Jubilant Bevco Limited
Sanjay Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jubilant Therapeutics India?
Jubilant Therapeutics India has a workforce of 13 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jubilant Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Therapeutics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Jubilant Therapeutics India
Recent activity within the organization
- Annual General Meeting
Jubilant Therapeutics India Limited last Annual general meeting of members was held on 29 Aug 2024 as per latest MCA records.
- Balance Sheet
Jubilant Therapeutics India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
- Director Appointment
Sanjay Gupta was appointed as a Director was appointed as a Director on 16 Jul 2021 & has been associated with this company since 3 years 8 months .
- Director Appointment
Arvind Chokhany was appointed as a Director was appointed as a Director on 03 Jun 2021 & has been associated with this company since 3 years 9 months .
- Director Appointment
Shyam Pattabiraman was appointed as a Director was appointed as a Director on 08 Sep 2020 & has been associated with this company since 4 years 6 months .
- Director Appointment
Arun Kumar Sharma was appointed as a Cfo was appointed as a Cfo on 18 Sep 2019 & has been associated with this company since 5 years 6 months .
Frequently asked questions
What is the Incorporation or founding date of Jubilant Therapeutics India Limited?
Jubilant Therapeutics India Limited was incorporated on 20 Mar 2019.
What is authorized share capital and paid-up capital of Jubilant Therapeutics India Limited?
The authorized share capital of Jubilant Therapeutics India Limited is ₹ 86.65 Cr and paid-up capital is ₹ 86.65 Cr.
Who are the current board members & directors of Jubilant Therapeutics India Limited?
Currently 6 directors are associated with Jubilant Therapeutics India Limited.
- Sanjay Gupta
- Shyam Pattabiraman
- Arvind Chokhany
- Sridharan Rajagopal
- Arun Kumar Sharma
- Anil Sharma
What is the registered address of Jubilant Therapeutics India Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Jubilant Therapeutics India Limited is 1-A Sector 16 A India, Noida, Uttar Pradesh, 201301.
What is the corporate identification number (CIN) and company number of Jubilant Therapeutics India Limited?
The corporate identification number (CIN) of Jubilant Therapeutics India Limited is U74994UP2019PLC114901 and the company number is 114901 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Jubilant Therapeutics India Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Jubilant Therapeutics India Limited has risen by 221.60%.
How many employees does Jubilant Therapeutics India Limited currently have?
As Per 2023 financial reports, 13 employees are currently employed by Jubilant Therapeutics India Limited.
What change has been observed in the net worth of Jubilant Therapeutics India Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Jubilant Therapeutics India Limited has experienced an upsurge of 11.29%.
When was the last Balance Sheet of Jubilant Therapeutics India Limited filed with the ROC?
The most recent Balance Sheet for Jubilant Therapeutics India Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
Alok VaishAdditional DirectorSR
Sankaraiah RajagopalDirectorRS
Rajesh SrivastavaDirectorAS
Arun SharmaDirector